ATS 2024 Final Program

Click on the session title to view the speakers

240

TUESDAY • MAY 21

P808 Monoclonal Antibodies for Allergic Bronchopulmonary Aspergillosis: A Case Series P809 Use of the Anti-interleukin-5-Receptor Monoclonal Antibody, Benralizumab, for the Treatment of Allergic Bronchopulmonary Aspergillosis P810 An Example of Tezepelumab Used to Treat Occupational Asthma P811 A Breath of Hope Turns to Heartbreak: Cardiac Arrest From Aerosolized Epinephrine Overuse for Undiagnosed Allergic Bronchopulmonary Aspergillosis P812 A Case of Anaphylaxis Associated Thrombocytopenia P813 Hyperimmunoglobulin E Syndrome: A Rare Autoimmune Masquerade of Th2 Asthma P814 Pneumatoceles and Bronchopleural Fistulas in a Patient With Hyper-IgE Syndrome P815 Tick Borne Disease, Ehrlichosis as Risk Factor for Alpha-gal Syndrome: A Case Report P816 Life-threatening Mast Cell Activation and Anaphylaxis in Mast Cell Leukemia and the Role of Omalizumab P817 Psoriasiform Dermatitis During Dupilumab Treatment in Asthma and Allergic Bronchopulmonary Aspergillosis (ABPA) P818 A Rare Case of Acquired Bradykinin Mediated Angioedema Associated With Chronic Lymphocytic Leukemia P819 Bronchoprovocation Test Gone Awry P820 Can’t Catch a Breath: Acute Eosinophilic Pneumonia in a Pregnant Female P821 Persistence of Severe Asthma With a T2 Phenotype Following Stem-Cell Transplant P822 Asthma as an Immune-Related Adverse Effect of Pembrolizumab P823 Ketamine Chronicles: A Breath of Fresh Air in Status Asthmaticus P824 A Combination of Tezepelumab and Omalizumab for Severe Persistent Asthma P825 A Case Review of Safety and Efficacy of Benralizumab in Haemodialysis Patients With Severe Eosinophilic Asthma

P620 Investigating Allergen-induced Acute Lung Inflammation in Asthmatic Individuals Using Breath Biopsies P621 Acute Asthma Outcomes Comparison: Low and Medium Dose Inhaled Corticosteroids After Hospitalization P622 Association Between Bronchial Asthma and TSLP Gene Polymorphism: A Systematic Review and Meta-analysis P623 Rheumatoid Arthritis Associated Asthma Exacerbations: A National Inpatient Sample 2016-2020 P624 An Observational and Translational Pilot Study Phenotyping the Response to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): Interim Results P625 Phenotype Characterization and Biomarker Evaluation in Moderate to Severe Type 2-high Asthma P626 ALbuterol-budesonide Treatment in Acute Airway Obstruction: Design of the ALTA Study P627 Patient Insights on Living With Type 2 Inflammation: A Community Survey P628 Gaps in Asthma Severity and Asthma Control Between Clinical Practice and Guideline According to a Real-World Survey in China

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

C32 ALL THAT WHEEZES (AND THEN SOME): CASE STUDIES 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P807 Hidden on Plain Film: Asymptomatic Allergic San Diego Convention Center Area H (Hall H, Ground Level)

Bronchopulmonary Aspergillosis With Mucoid Impaction of the Right Mainstem Bronchus

ATS 2024 Conference Program • San Diego, CA